GGrantIndex
← Search

Integrated Microscopy

$95,697P30FY2022CANIH

University Of Chicago, Chicago IL

Investigators

Linked publications, trials & patents

Paper 39661064Paper 39579248Paper 39438113Paper 39374047Paper 39270007Paper 39141403Paper 39114540Paper 39108474Paper 39071306Paper 39069988Paper 38883758Paper 38881356Paper 38849889Paper 38810242Paper 38771643Paper 38752924Paper 38735044Paper 38716867Paper 38691450Paper 38632339Paper 38561491Paper 38548994Paper 38536082Paper 38533736Paper 38496521Paper 38427437Paper 38421866Paper 38381713Paper 38294692Paper 38294689Paper 38293065Paper 38219706Paper 38213818Paper 38190286Paper 38186960Paper 38175791Paper 38155245Trial NCT02573363Trial NCT02573220Trial NCT02542202Trial NCT02540876Trial NCT02485535Trial NCT02420210Trial NCT02399371Trial NCT02389517Trial NCT02366819Trial NCT02333188Trial NCT02333162Trial NCT02275533Trial NCT02258659Trial NCT02213913Trial NCT02199665Trial NCT02122172Trial NCT02046421Trial NCT02012296Trial NCT01949740Trial NCT01861301Trial NCT01696955Trial NCT01576172Trial NCT01307618Trial NCT01281176Trial NCT01278615Trial NCT01267266Trial NCT01256385Trial NCT01208051Trial NCT01174264Trial NCT01122888Trial NCT01076543Trial NCT01064622Trial NCT00859937Trial NCT00720174Trial NCT00504153Trial NCT00436579Trial NCT00387335Trial NCT00381641Trial NCT00376688Trial NCT00369551Trial NCT00351975Trial NCT00303862Trial NCT00290472Trial NCT00265798Trial NCT00126542Trial NCT00095784Trial NCT00091026Trial NCT00087373Trial NCT00062075Trial NCT00058019Trial NCT00055913Trial NCT00039416Trial NCT00027703Trial NCT00023946Patent 7192711Patent 6870037Patent 6482934Patent 6387619Patent 6043216Patent 5916752Patent 5786344Patent 5698686Patent 5618917

Abstract

ABSTRACT The Integrated Microscopy Facility (IMF) functions as a supervised, user-based Core providing state-of-the-art microscopy imaging capabilities to University of Chicago Medicine Comprehensive Cancer Center (UCCCC) members and other University investigators. Light microscopy is an essential technology for cancer investigators. Modern microscopy enables observation of ever-finer detail, now breaking the optical diffraction barrier to yield super-resolution detail, thus providing information at scales ranging from tens of millimeters to less than 10 nanometers. The IMF offers all major wide-field and confocal techniques in addition to super- resolution technologies (e.g., stimulated emission depletion (STED), localization, structured light), and works to advance these methodologies for application to cancer research. Specific IMF developments in the current funding period include significant upgrades to microscope technologies and data analysis tools. Notably, these include installation of GSD super-resolution, a Lightsheet.z1 system, a SP8 white-light-laser spectral confocal, additional high-end workstations and upgrade to full-feature Imaris software. IMF staff additionally provides equipment maintenance, user training, and expert advice. Budgets reflect strictly a cost-recovery operation, with all services provided “at-cost”. As an integrated Core, IMF allows for efficient pooling of resources and management, while creating a large user base that aids in leveraging support from the University as well as other agencies and keeping costs low. Half of the IMF usage is associated with research conducted by UCCCC members. Specifically, UCCCC labs are major users of the IMF; for any given service that approaches capacity usage, every effort is made to ensure priority access for UCCCC investigators. Institutional support mechanisms significantly enhance UCCCC research efforts within the IMF. The Biological Science Division (BSD) invested $1,001,408 in the Core in 2016 alone to purchase equipment requested by UCCCC members. The Core supported the work of 99 UCCCC investigators in the current funding period (2013-2016), which included 647 individual users of IMF services.

View original record on NIH RePORTER →